Grouping nanomaterials to predict their potential to induce pulmonary inflammation

Toxicology and Applied Pharmacology

Volumn 299, Issue , 2016, Pages 3-7

  Braakhuis, Hedwig M ^a,b   Oomen, Agnes G ^a   Cassee, Flemming R ^a,c  

^a NATIONAL INSTITUTE FOR PUBLIC HEALTH AND THE ENVIRONMENT   (Netherlands)

^b MAASTRICHT UNIVERSITY   (Netherlands)

^c UTRECHT UNIVERSITY   (Netherlands)

Author keywords

Grouping; Inhalation toxicology; Nanoparticles; Risk assessment

Indexed keywords

DEODORANT AGENT; NANOMATERIAL; SILVER NANOPARTICLE; METAL NANOPARTICLE;

ANALYTIC METHOD; ARTICLE; CHEMICAL REACTION KINETICS; EXPOSURE; GROUPING TECHNIQUE; HAZARD ASSESSMENT; PHYSICAL CHEMISTRY; RISK ASSESSMENT; ADVERSE EFFECTS; ANIMAL; CHEMICALLY INDUCED; CLASSIFICATION; FORECASTING; HUMAN; PARTICLE SIZE; PNEUMONIA;

ANIMALS; FORECASTING; HUMANS; INHALATION EXPOSURE; METAL NANOPARTICLES; NANOSTRUCTURES; PARTICLE SIZE; PNEUMONIA;

EID: 84949591411     PISSN: 0041008X     EISSN: 10960333     Source Type: Journal    
DOI: 10.1016/j.taap.2015.11.009     Document Type: Article

References (75)

1. (SCENIHR), S. C. O. E. A. N. I. H. R., De Jong, W., DR., Bridges, J., PROF., Dawson, K., PROF., Jung, T., DR. & Proykova, A., PROF. 2010. Scientific basis for the definition of the term 'nanomaterial'. Brussels, Belgium: European Commission.
2. Arts J.H., Hadi M., Keene A.M., Kreiling R., Lyon D., Maier M., Michel K., Petry T., Sauer U.G., Warheit D., Wiench K., Landsiedel R. A critical appraisal of existing concepts for the grouping of nanomaterials. Regul. Toxicol. Pharmacol. 2014, 70:492-506.
3. Arts J.H., Hadi M., Irfan M.A., Keene A.M., Kreiling R., Lyon D., Maier M., Michel K., Petry T., Sauer U.G., Warheit D., Wiench K., Wohlleben W., Landsiedel R. A decision-making framework for the grouping and testing of nanomaterials (DF4nanoGrouping) 2015, Regul Toxicol Pharmacol.
4. Asati A., Santra S., Kaittanis C., Perez J.M. Surface-charge-dependent cell localization and cytotoxicity of cerium oxide nanoparticles. ACS Nano 2010, 4:5321-5331.
5. Asgharian B., Price O., Miller F., Subramaniam R., Cassee F.R., Freijer J., Van Bree L., Winter-Sorkina R. Multiple-Path Particle Dosimetry Model (MPPD v 2.11): A Model for Human and Rat Airway Particle Dosimetry 2009, Applied Research Associates (ARA), Raleigh, North Carolina, USA. V2.11 ed. Applied Research Associates (ARA), H. I. F. H. S., National Institute For Public Health and The Environment (RIVM), Ministry Of Housing, Spatial Planning and The Environment (Eds.).
6. Bakand S., Hayes A., Dechsakulthorn F. Nanoparticles: a review of particle toxicology following inhalation exposure. Inhal. Toxicol. 2012, 24:125-135.
7. Bolt H.M. Grouping of nanomaterials for risk assessment. Arch. Toxicol. 2014, 88:2077-2078.
8. Braakhuis H.M., Park M.V., Gosens I., De Jong W.H., Cassee F.R. Physicochemical characteristics of nanomaterials that affect pulmonary inflammation. Part. Fibre Toxicol. 2014, 11:18.
9. Card J.W., Magnuson B.A. A method to assess the quality of studies that examine the toxicity of engineered nanomaterials. Int. J. Toxicol. 2010, 29:402-410.
10. Carvalho T.C., Peters J.I., Williams R.O. Influence of particle size on regional lung deposition-what evidence is there?. Int. J. Pharm. 2011, 406:1-10.
11. Cassee F.R., Muijser H., Duistermaat E., Freijer J.J., Geerse K.B., Marijnissen J.C., Arts J.H. Particle size-dependent total mass deposition in lungs determines inhalation toxicity of cadmium chloride aerosols in rats. Application of a multiple path dosimetry model. Arch. Toxicol. 2002, 76:277-286.
12. Cheng L.C., Jiang X., Wang J., Chen C., Liu R.S. Nano-bio effects: interaction of nanomaterials with cells. Nanoscale 2013, 5:3547-3569.
13. Cho W.S., Duffin R., Howie S.E., Scotton C.J., Wallace W.A., Macnee W., Bradley M., Megson I.L., Donaldson K. Progressive severe lung injury by zinc oxide nanoparticles; the role of Zn2+ dissolution inside lysosomes. Part, Fibre Toxicol. 2011, 8:27.
14. Cho W.S., Duffin R., Poland C.A., Duschl A., Oostingh G.J., Macnee W., Bradley M., Megson I.L., Donaldson K. Differential pro-inflammatory effects of metal oxide nanoparticles and their soluble ions in vitro and in vivo; zinc and copper nanoparticles, but not their ions, recruit eosinophils to the lungs. Nanotoxicology 2012, 6:22-35.
15. Cho W.S., Duffin R., Thielbeer F., Bradley M., Megson I.L., Macnee W., Poland C.A., Tran C.L., Donaldson K. Zeta potential and solubility to toxic ions as mechanisms of lung inflammation caused by metal/metal oxide nanoparticles. Toxicol. Sci. 2012, 126:469-477.
16. Choi H.S., Liu W., Misra P., Tanaka E., Zimmer J.P., Itty Ipe B., Bawendi M.G., Frangioni J.V. Renal clearance of quantum dots. Nat. Biotechnol. 2007, 25:1165-1170.
17. Choi H.S., Ashitate Y., Lee J.H., Kim S.H., Matsui A., Insin N., Bawendi M.G., Semmler-Behnke M., Frangioni J.V., Tsuda A. Rapid translocation of nanoparticles from the lung airspaces to the body. Nat. Biotechnol. 2010, 28:1300-1303.
18. Christensen F.M., Johnston H.J., Stone V., Aitken R.J., Hankin S., Peters S., Aschberger K. Nano-silver - feasibility and challenges for human health risk assessment based on open literature. Nanotoxicology 2010, 4:284-295.
19. Donaldson K., Stone V., Clouter A., Renwick L., Macnee W. Ultrafine particles. Occup. Environ. Med. 2001, 58(211-6):199.
20. Donaldson K., Murphy F.A., Duffin R., Poland C.A. Asbestos, carbon nanotubes and the pleural mesothelium: a review of the hypothesis regarding the role of long fibre retention in the parietal pleura, inflammation and mesothelioma. Part, Fibre Toxicol. 2010, 7:5.
21. Donaldson K., Schinwald A., Murphy F., Cho W.S., Duffin R., Tran L., Poland C. The biologically effective dose in inhalation nanotoxicology. Acc. Chem. Res. 2012.
22. Donaldson K., Schinwald A., Murphy F., Cho W.S., Duffin R., Tran L., Poland C. The biologically effective dose in inhalation nanotoxicology. Acc. Chem. Res. 2013, 46:723-732.
23. Elsaesser A., Howard C.V. Toxicology of nanoparticles. Adv. Drug Deliv. Rev. 2012, 64:129-137.
24. Gebel T., Foth H., Damm G., Freyberger A., Kramer P.J., Lilienblum W., Rohl C., Schupp T., Weiss C., Wollin K.M., Hengstler J.G. Manufactured nanomaterials: categorization and approaches to hazard assessment. Arch. Toxicol. 2014, 88:2191-2211.
25. Geiser M. Update on macrophage clearance of inhaled micro- and nanoparticles. J. Aerosol Med. Pulm. Drug Deliv. 2010, 23:207-217.
26. Geiser M., Casaulta M., Kupferschmid B., Schulz H., Semmler-Behnke M., Kreyling W. The role of macrophages in the clearance of inhaled ultrafine titanium dioxide particles. Am. J. Respir. Cell Mol. Biol. 2008, 38:371-376.
27. Geraets L., Oomen A.G., Schroeter J.D., Coleman V.A., Cassee F.R. Tissue distribution of inhaled micro- and Nano-sized cerium oxide particles in rats: results from a 28-day exposure study. Toxicol. Sci. 2012, 127:463-473.
28. Gessner A., Lieske A., Paulke B., Muller R. Influence of surface charge density on protein adsorption on polymeric nanoparticles: analysis by two-dimensional electrophoresis. Eur. J. Pharm. Biopharm. 2002, 54:165-170.
29. Heinrich U., Fuhst R., Rittinghausen S., Creutzenberg O., Bellmann B., Koch W., Levsen K. Chronic inhalation exposure of Wistar rats and two different strains of mice to diesel exhaust, carbon black and titanium dioxide. Inhal. Toxicol. 1995, 7:23.
30. Hinds W.C. Chapter 12. Aerosol technology: properties, behavior and measurement of airborne particles 1982, John Wiley & Sons, New York.
31. Hornung V., Bauernfeind F., Halle A., Samstad E.O., Kono H., Rock K.L., Fitzgerald K.A., Latz E. Silica crystals and aluminum salts activate the NALP3 inflammasome through phagosomal destabilization. Nat. Immunol. 2008, 9:847-856.
32. ICRP Human respiratory tract model for radiological protection. ICRP publication 1994, 66. International Commission on Radiological Protection.
33. Ji J.H., Jung J.H., Kim S.S., Yoon J.U., Park J.D., Choi B.S., Chung Y.H., Kwon I.H., Jeong J., Han B.S., Shin J.H., Sung J.H., Song K.S., Yu I.J. Twenty-eight-day inhalation toxicity study of silver nanoparticles in Sprague-Dawley rats. Inhal. Toxicol. 2007, 19:857-871.
34. Knaapen A.M., Borm P.J., Albrecht C., Schins R.P. Inhaled particles and lung cancer. Part A: mechanisms. Int. J. Cancer 2004, 109:799-809.
35. Koch W., Stober W. A simple pulmonary retention model accounting for dissolution and macrophage-mediated removal of deposited polydisperse particles. Inhal. Toxicol. 2001, 13:129-148.
36. Kreyling W.G. Intracellular particle dissolution in alveolar macrophages. Environ. Health Perspect. 1992, 97:121-126.
37. Kreyling W.G., Semmler-Behnke M., Seitz J., Scymczak W., Wenk A., Mayer P., Takenaka S., Oberdorster G. Size dependence of the translocation of inhaled iridium and carbon nanoparticle aggregates from the lung of rats to the blood and secondary target organs. Inhal. Toxicol. 2009, 21(Suppl. 1):55-60.
38. Landsiedel R., Ma-Hock L., Kroll A., Hahn D., Schnekenburger J., Wiench K., Wohlleben W. Testing metal-oxide nanomaterials for human safety. Adv. Mater. 2010, 22:2601-2627.
39. Maynard A.D., Kuempel E.D. Airborne nanostructured particles and occupational health. J. Nanoparticle Res. 2005, 7:587-614.
40. Mcclellan R.O., Henderson R.F. Concepts in inhalation toxicology 1995, Taylor & Francis, Washington.
41. Moller P., Jacobsen N.R., Folkmann J.K., Danielsen P.H., Mikkelsen L., Hemmingsen J.G., Vesterdal L.K., Forchhammer L., Wallin H., Loft S. Role of oxidative damage in toxicity of particulates. Free Radic. Res. 2010, 44:1-46.
42. Muhlfeld C., Gehr P., Rothen-Rutishauser B. Translocation and cellular entering mechanisms of nanoparticles in the respiratory tract. Swiss Med. Wkly. 2008, 138:387-391.
43. Muhlfeld C., Rothen-Rutishauser B., Blank F., Vanhecke D., Ochs M., Gehr P. Interactions of nanoparticles with pulmonary structures and cellular responses. Am. J. Physiol. Lung Cell. Mol. Physiol. 2008, 294:L817-L829.
44. Nagy A., Steinbruck A., Gao J., Doggett N., Hollingsworth J.A., Iyer R. Comprehensive analysis of the effects of CdSe quantum dot size, surface charge, and functionalization on primary human lung cells. ACS Nano 2012, 6:4748-4762.
45. NANOTECHNOLOGIES, P.O.E. Consumer products inventory [online] Available:, (Accessed June 2014). http://www.nanotechproject.org/cpi.
46. Nel A., Xia T., Madler L., Li N. Toxic potential of materials at the nanolevel. Science 2006, 311:622-627.
47. Nel A.E., Madler L., Velegol D., Xia T., Hoek E.M., Somasundaran P., Klaessig F., Castranova V., Thompson M. Understanding biophysicochemical interactions at the nano-bio interface. Nat. Mater. 2009, 8:543-557.
48. Noel A., Maghni K., Cloutier Y., Dion C., Wilkinson K.J., Halle S., Tardif R., Truchon G. Effects of inhaled nano-TiO2 aerosols showing two distinct agglomeration states on rat lungs. Toxicol. Lett. 2012, 214:109-119.
49. Oberdorster G., Ferin J., Lehnert B.E. Correlation between particle size, in vivo particle persistence, and lung injury. Environ. Health Perspect. 1994, 102(Suppl. 5):173-179.
50. Oberdorster G., Finkelstein J.N., Johnston C., Gelein R., Cox C., Baggs R., Elder A.C. Acute pulmonary effects of ultrafine particles in rats and mice. Res. Rep. Health Eff. Inst. 2000, 5-74. (disc 75-86).
51. Oberdorster G., Oberdorster E., Oberdorster J. Nanotoxicology: an emerging discipline evolving from studies of ultrafine particles. Environ. Health Perspect. 2005, 113:823-839.
52. Oomen A.G., M.B., Engelen J., Sips A.J. Nanomaterial in consumer products: detection, characterisation and interpretation. RIVM Rapp. 2011, 320029001.
53. Oomen A.G., Bos P.M., Fernandes T.F., Hund-Rinke K., Boraschi D., Byrne H.J., Aschberger K., Gottardo S., Von Der Kammer F., Kuhnel D., Hristozov D., Marcomini A., Migliore L., Scott-Fordsmand J., Wick P., Landsiedel R. Concern-driven integrated approaches to nanomaterial testing and assessment-report of the NanoSafety cluster working group 10. Nanotoxicology 2014, 8:334-348.
54. Oomen A.G., Bleeker E., Bos P.M., Van Broekhuizen F., Gottardo S., Groenewold M., Hristozov D., Hund-Rinke K., Irfan M.A., Marcomini A., Peijnenburg W.J., Rasmussen K., Jimenez A.S., Scott-Fordsmand J.J., Van Tongeren M., Wiench K., Wohlleben W., Landsiedel R. Grouping and Read-Across Approaches for Risk Assessment of Nanomaterials. Int. J. Environ. Res. Public Health 2015, 12:13415-13434.
55. Pauluhn J. Pulmonary toxicity and fate of agglomerated 10 and 40 nm aluminum oxyhydroxides following 4-week inhalation exposure of rats: toxic effects are determined by agglomerated, not primary particle size. Toxicol. Sci. 2009, 109:152-167.
56. Pauluhn J. Poorly soluble particulates: searching for a unifying denominator of nanoparticles and fine particles for DNEL estimation. Toxicology 2011, 279:176-188.
57. Phalen R.F., Mendez L.B., Oldham M.J. New developments in aerosol dosimetry. Inhal. Toxicol. 2010, 22(Suppl. 2):6-14.
58. Porter D.W., Wu N., Hubbs A., Mercer R., Funk K., Meng F., Li J., Wolfarth M., Battelli L., Friend S., Andrew M., Hamilton R., Sriram K., Yang F., Castranova V., Holian A. Differential mouse pulmonary dose- and time course-responses to titanium dioxide nanospheres and nanobelts. Toxicol. Sci. 2012.
59. Porter D.W., Wu N., Hubbs A.F., Mercer R.R., Funk K., Meng F., Li J., Wolfarth M.G., Battelli L., Friend S., Andrew M., Hamilton R., Sriram K., Yang F., Castranova V., Holian A. Differential mouse pulmonary dose and time course responses to titanium dioxide nanospheres and nanobelts. Toxicol. Sci. 2013, 131:179-193.
60. Sanchez V.C., Jachak A., Hurt R.H., Kane A.B. Biological interactions of graphene-family nanomaterials: an interdisciplinary review. Chem. Res. Toxicol. 2012, 25:15-34.
61. Sayes C.M., Smith P.A., Ivanov I.V. A framework for grouping nanoparticles based on their measurable characteristics. Int. J. Nanomedicine 2013, 8(Suppl. 1):45-56.
62. Schinwald A., Chernova T., Donaldson K. Use of silver nanowires to determine thresholds for fibre length-dependent pulmonary inflammation and inhibition of macrophage migration in vitro. Part. Fibre Toxicol. 2012, 9:47.
63. Schinwald A., Murphy F.A., Jones A., Macnee W., Donaldson K. Graphene-based nanoplatelets: a new risk to the respiratory system as a consequence of their unusual aerodynamic properties. ACS Nano 2012, 6:736-746.
64. Shvedova A.A., Kisin E.R., Mercer R., Murray A.R., Johnson V.J., Potapovich A.I., Tyurina Y.Y., Gorelik O., Arepalli S., Schwegler-Berry D., Hubbs A.F., Antonini J., Evans D.E., Ku B.K., Ramsey D., Maynard A., Kagan V.E., Castranova V., Baron P. Unusual inflammatory and fibrogenic pulmonary responses to single-walled carbon nanotubes in mice. Am. J. Physiol. Lung Cell. Mol. Physiol. 2005, 289:L698-L708.
65. Stoehr L.C., Gonzalez E., Stampfl A., Casals E., Duschl A., Puntes V., Oostingh G.J. Shape matters: effects of silver nanospheres and wires on human alveolar epithelial cells. Part. Fibre Toxicol. 2011, 8:36.
66. Sung J.H., Ji J.H., Park J.D., Yoon J.U., Kim D.S., Jeon K.S., Song M.Y., Jeong J., Han B.S., Han J.H., Chung Y.H., Chang H.K., Lee J.H., Cho M.H., Kelman B.J., Yu I.J. Subchronic inhalation toxicity of silver nanoparticles. Toxicol. Sci. 2009, 108:452-461.
67. Van Ravenzwaay B., Landsiedel R., Fabian E., Burkhardt S., Strauss V., Ma-Hock L. Comparing fate and effects of three particles of different surface properties: nano-TiO(2), pigmentary TiO(2) and quartz. Toxicol. Lett. 2009, 186:152-159.
68. Varghese S.K., Gangamma S. Particle deposition in human respiratory system: deposition of concentrated hygroscopic aerosols. Inhal. Toxicol. 2009, 21:619-630.
69. Wang L., Ding W., Zhang F. Acute toxicity of ferric oxide and zinc oxide nanoparticles in rats. J. Nanosci. Nanotechnol. 2010, 10:8617-8624.
70. Warheit D.B., Webb T.R., Colvin V.L., Reed K.L., Sayes C.M. Pulmonary bioassay studies with nanoscale and fine-quartz particles in rats: toxicity is not dependent upon particle size but on surface characteristics. Toxicol. Sci. 2007, 95:270-280.
71. Warheit D.B., Webb T.R., Reed K.L., Frerichs S., Sayes C.M. Pulmonary toxicity study in rats with three forms of ultrafine-TiO2 particles: differential responses related to surface properties. Toxicology 2007, 230:90-104.
72. Wijnhoven S.W.P., Dekkers S., Kooi M., Jongeneel R., Jong W.H. Nanomaterials in consumer products: update of products on the European market in 2010. RIVM Rapp. 2010, 340370003.
73. Yang W., Peters J.I., Williams R.O. Inhaled nanoparticles-a current review. Int. J. Pharm. 2008, 356:239-247.
74. YAZDI A.S., GUARDA G., RITEAU N., DREXLER S.K., TARDIVEL A., COUILLIN I., TSCHOPP J. Nanoparticles activate the NLR pyrin domain containing 3 (Nlrp3) inflammasome and cause pulmonary inflammation through release of IL-1alpha and IL-1beta. Proc. Natl. Acad. Sci. U. S. A. 2010, 107:19449-19454.
75. Zhang L.W., Baumer W., Monteiro-Riviere N.A. Cellular uptake mechanisms and toxicity of quantum dots in dendritic cells. Nanomedicine (London) 2011, 6:777-791.